Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 25;2(1):e000263.
doi: 10.1136/rmdopen-2016-000263. eCollection 2016.

Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES

Gianfranco Ferraccioli  1 , Barbara Tolusso  1 , Anna Laura Fedele  1 , Elisa Gremese  1
Affiliations

Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES

Gianfranco Ferraccioli et al. RMD Open. .
No abstract available

Keywords: Ant-CCP; Disease Activity; Early Rheumatoid Arthritis; Rheumatoid Arthritis; Rheumatoid Factor.

PubMed Disclaimer

References

    1. Combe B, Landewe R, Lukas C et al. . EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34–45. 10.1136/ard.2005.044354 - DOI - PMC - PubMed
    1. Smolen JS, Breedveld FC, Burmester GR et al. . Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75:3–15. - PMC - PubMed
    1. Smolen JS, Landewé R, Breedveld FC et al. . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014;73:492–509. 10.1136/annrheumdis-2013-204573 - DOI - PMC - PubMed
    1. de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN et al. . Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti- citrullinated protein antibodies in relation to different treatment strategies. Arthritis Rheum 2008;58:1293–8. 10.1002/art.23439 - DOI - PubMed
    1. Akdemir G, Markusse I, Dirven L et al. . Effectiveness of four dynamic treatment strategies in patients with anti-citrullinated antibody-negative rheumatoid arthritis—a randomised trial. RMD Open 2016; Published Online First Mar 2016.10.1136/rmdopen-2015-000143 - DOI - PMC - PubMed

LinkOut - more resources